SciClone Pharmaceuticals (Holdings) Ltd - ESG Rating & Company Profile powered by AI
If you work at SciClone Pharmaceuticals (Holdings) Ltd and you wish to use your ESG aseessment, please contact us. This ESG rating covers seventeen UN SDGs including: 'No Poverty', 'Responsible Production & Consumption' and 'Life on Land'. This assessment of SciClone Pharmaceuticals (Holdings) Ltd employs intelligence from across the internet and also from public filings by SciClone Pharmaceuticals (Holdings) Ltd.
SciClone Pharmaceuticals (Holdings) Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | SciClone Pharmaceuticals (Holdings) Ltd | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does SciClone Pharmaceuticals (Holdings) Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd report the average age of the workforce?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd offer flexible work?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd conduct supply chain audits?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose water use targets?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid SciClone Pharmaceuticals (Holdings) Ltd have a product recall in the last two years?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas SciClone Pharmaceuticals (Holdings) Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose parental leave metrics?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs SciClone Pharmaceuticals (Holdings) Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose its waste policy?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd report according to TCFD requirements?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose energy use targets?
Sign up for free to unlockDoes SciClone Pharmaceuticals (Holdings) Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes SciClone Pharmaceuticals (Holdings) Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for SciClone Pharmaceuticals (Holdings) Ltd
These potential risks are based on the size, segment and geographies of the company.
SciClone Pharmaceuticals (Holdings) Limited, a biopharmaceutical company, engages in the development and commercialization pharmaceutical products in the therapeutic areas of oncology and severe infection in Mainland China and internationally. The company's proprietary product is Zadaxin, a thymalfasin for Injection. Its in-licensed products include Angiomax, an anticoagulant for use in patients undergoing percutaneous coronary intervention comprising patients with heparin-induced thrombocytopenia and thrombosis syndrome; and Zometa for the treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors, and hypercalcemia of malignancy. The company also sells promotion products on behalf of its business partners. SciClone Pharmaceuticals (Holdings) Limited was founded in 1990 and is headquartered in Shanghai, the People's Republic of China.